Ovid Therapeutics Inc (OVID) Directors and Executive Officers - CSIMarket
CSIMarket
 
Ovid Therapeutics Inc   (NASDAQ: OVID)

Ovid Therapeutics Inc

Officers & Directors


Executives:

1. Jeremy M. Levin, DPhil, MB BChir - Chief Executive Officer and Director (Principal Executive Officer)
Jeremy Levin is the Chief Executive Officer of Ovid Therapeutics. He has more than two decades of experience in the biopharmaceutical industry. Before joining Ovid, he served as the President and CEO of Teva Pharmaceutical Industries Ltd. Previously, he worked at Bristol-Myers Squibb and Genentech.

2. Jeffrey Rona - Chief Business and Financial Officer (Principal Financial and Accounting Officer)
Jeffrey Rona is the Chief Business and Financial Officer at Ovid Therapeutics.

Directors:

1. Karen Bernstein, PhD - Director

2. Bart Friedman - Director

3. Kevin Fitzgerald, PhD - Director

4. Barbara Duncan - Director

5. Robert Michael Poole, MD, FACP - Director

6. Stephen Squinto, PhD - Lead Independent Director
Stephen Squinto is the Lead Independent Director at Ovid Therapeutics. He is a scientist and has more than 35 years of experience in the biopharmaceutical industry. Previously, he worked at Alexion Pharmaceuticals and Regeneron Pharmaceuticals.

7. Rachel Sherman, MD, MPH - Independent Director
Rachel Sherman is an Independent Director at Ovid Therapeutics. She is a physician and has more than 25 years of experience in drug development and regulation. Previously, she worked at the US Food and Drug Administration (FDA) as a Deputy Commissioner.

8. Jane Wasman - Independent Director
Jane Wasman is an Independent Director at Ovid Therapeutics. She has more than 30 years of experience in the biopharmaceutical industry. Previously, she worked at Acorda Therapeutics and Pfizer.

Auditor:

- - Auditor
has served as the Company’s auditor since...,

Ovid Therapeutics Inc currently has 23 employees.






OVID Management Effectiveness OVID Revenue per Employee OVID Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.